NCT00130949View on ClinicalTrials.gov

ALGRX 4975 in the Treatment of Tennis Elbow

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

November 30, 2005

Conditions
Tennis Elbow
Interventions
DRUG

ALGRX 4975

Trial Locations (1)

040 11

Ortopedicko-Traumatologicka Klinika, Košice

Sponsors
All Listed Sponsors
lead

AlgoRx Pharmaceuticals

INDUSTRY

NCT00130949 - ALGRX 4975 in the Treatment of Tennis Elbow | Biotech Hunter | Biotech Hunter